Introduction Recent changes in funding policies from the U.S. government have caused a ripple effect in the landscape of clinical trials for childhood cancer. With at least five innovative clinical trials in Canada now closed to new patients, the implications of these funding cuts on young cancer patients are severe. This article delves into the…